Evolent Health EVH
NYSE EVH
$4.32 +0.05 (+1.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Evolent Health (EVH) Asset Writedowns and Impairment (2020 - 2024)

Evolent Health (EVH) posted Asset Writedowns and Impairment of $2.6 million for Q4 2024, down 89.25% on a QoQ basis from $24.1 million in Q2 2023.

Analysis

Evolent Health (EVH) Asset Writedowns and Impairment (2020 - 2024) Analysis & Trends

Evolent Health has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $2.6 million in Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $2.6 million in Q4 2024; TTM through Dec 2024 was $2.6 million, a 89.25% decrease from a year earlier, with the FY2024 full-year figure at $2.6 million, down 89.25% from the prior year.
  • Asset Writedowns and Impairment was $2.6 million for Q4 2024 at Evolent Health, down from $24.1 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $47.1 million in Q1 2020, with the low at $2.6 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $24.6 million, with a median of $24.1 million recorded in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.76 Bn 12.64 Bn 1.16 Bn
2 RadNet 5.80 Bn 5.37 Bn 88.08 Mn
3 Concentra Group Holdings Parent 4.40 Bn 4.26 Bn 192.10 Mn
4 Privia Health 2.61 Bn 2.25 Bn -
5 Pediatrix Medical 2.20 Bn 1.79 Bn -
6 Fresenius Medical Care AG 2.11 Bn 1.41 Bn 1.52 Bn
7 Progyny 2.01 Bn 1.77 Bn 89.30 Mn
8 Surgery Partners 1.87 Bn 3.08 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.47 Bn 41.94 Mn
10 Evolent Health 488.42 Mn 346.95 Mn 80.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.59 Mn
Jun 30, 2023 24.07 Mn
Mar 31, 2020 47.13 Mn